CSPC Pharmaceutical Group Limited Share Price
Stocks
1093
HK1093012172
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
01:38:16 16/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 8.880 HKD | +0.17% |
|
-2.26% | +5.34% |
| 15/10 | CSPC Pharma Gets China Nod for Tumor Drug Trial | MT |
| 15/10 | CSPC Pharmaceutical Group Limited Obtains Clinical Trial Approval For SYS6088 Injection In China | CI |
| Market Cap | 10TCr 1.29TCr 1.15TCr 1.06TCr 968.3Cr 1.83TCr 1,22600Cr 1.86TCr 13TCr 5.02TCr 64TCr 4.85TCr 4.74TCr 2,03900Cr | P/E 2026 * |
10x | P/E 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 9.02TCr 1.15TCr 1.02TCr 946.51Cr 861.16Cr 1.63TCr 1,09000Cr 1.65TCr 11TCr 4.46TCr 57TCr 4.31TCr 4.22TCr 1,81400Cr | EV / Sales 2026 * |
2.34x | EV / Sales 2027 * | 2.44x |
| Free-Float |
67.42% | Yield 2026 * |
5.18% | Yield 2027 * | 4.15% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 1093 | Delayed | |
OTC Markets
| CHJTF | Delayed | |
|
Tradegate
| CVG | Real-time | |
|
Boerse Muenchen
| CVG | Real-time | |
|
Deutsche Boerse AG
| CVG | Delayed | |
|
Börse Stuttgart
| CVG | Delayed |
| 1 day | +0.17% | ||
| 1 week | -2.26% | ||
| Current month | -11.82% | ||
| 1 month | +0.85% | ||
| 3 months | +3.26% | ||
| 6 months | -5.03% | ||
| Current year | +5.34% |
| 1 week | 8.72 |  | 9.35 |
| 1 month | 8.72 | | 10.16 |
| Current year | 6.53 | | 10.96 |
| 1 year | 6.53 | | 10.96 |
| 3 years | 4.27 | | 11.63 |
| 5 years | 4.27 | | 11.63 |
| 10 years | 3.87 | | 13.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Cai
CEO | Chief Executive Officer | 46 | 19/12/2025 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 19/12/2025 |
Zhi Yong Qu
PRN | Corporate Officer/Principal | 44 | 01/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 26/08/2011 |
Zhen Guo Wang
BRD | Director/Board Member | 56 | 20/01/2012 |
Bo Wang
BRD | Director/Board Member | 66 | 21/12/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/06/26 | Other | Director | -7,00,000 | 0.0061% | ||
| 29/05/26 | Other | Chairman | 94,02,000 | 0.0816% | ||
| 28/05/26 | Other | Chairman | 4,00,00,000 | 0.3471% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.17% | -2.26% | -4.21% | +56.34% | 1.29TCr | |
| +0.43% | +6.59% | +53.41% | +103.85% | 1,12000Cr | |
| +0.90% | -2.25% | +33.02% | +62.23% | 62TCr | |
| +0.71% | +3.24% | +25.81% | +93.86% | 50TCr | |
| -0.13% | +5.98% | +32.91% | +50.39% | 37TCr | |
| +0.52% | +0.24% | +73.92% | +40.15% | 36TCr | |
| -0.95% | +4.70% | +19.51% | +43.00% | 29TCr | |
| -1.98% | +3.73% | -0.86% | +13.43% | 26TCr | |
| -0.35% | +4.25% | +46.21% | +50.76% | 23TCr | |
| -0.75% | +3.32% | +32.53% | +97.21% | 19TCr | |
| Average | -0.14% | +3.03% | +31.23% | +61.12% | 39.54TCr | |
| Weighted average by Cap. | +0.13% | +3.81% | +39.04% | +71.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.85TCr 490.32Cr 435.85Cr 403.97Cr 367.54Cr 693.57Cr 47TCr 704.69Cr 4.86TCr 1.9TCr 24TCr 1.84TCr 1.8TCr 77TCr | 3.57TCr 454.77Cr 404.25Cr 374.68Cr 340.9Cr 643.28Cr 43TCr 653.6Cr 4.5TCr 1.77TCr 23TCr 1.71TCr 1.67TCr 72TCr |
| Net income | 1.01TCr 129.25Cr 114.89Cr 106.49Cr 97Cr 182.82Cr 12TCr 185.75Cr 1.28TCr 501.85Cr 6.4TCr 485.06Cr 474.74Cr 20TCr | 701.83Cr 89Cr 79Cr 74Cr 67Cr 126.5Cr 8.49TCr 128.53Cr 885.66Cr 347.25Cr 4.43TCr 335.63Cr 328.48Cr 14TCr |
| Net Debt | -1.12TCr -142.93Cr -127.05Cr -117.76Cr -107.14Cr -202.18Cr -14TCr -205.42Cr -1.42TCr -554.98Cr -7.08TCr -536.42Cr -525Cr -23TCr | -1.43TCr -182.03Cr -161.81Cr -149.97Cr -136.45Cr -257.48Cr -17TCr -261.61Cr -1.8TCr -706.8Cr -9.02TCr -683.16Cr -668.61Cr -29TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | HK$8.880 | +0.17% | 7,28,99,598 |
| 15/26/15 | HK$8.865 | +0.62% | 6,40,18,514 |
| 14/26/14 | HK$8.810 | -2.81% | 6,35,88,814 |
| 13/26/13 | HK$9.065 | +0.44% | 4,49,16,142 |
| 12/26/12 | HK$9.025 | -0.66% | 5,91,27,086 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
Select your edition
All financial news and data tailored to specific country editions
